Category Archives: healthcare

CHC Stresses Privacy, First Amendment, Self-Regulation at DC meeting

This week members of the Coalition for Healthcare Communication (CHC) met to discuss issues in healthcare communications and marketing like privacy and security, off-label advertising and the Sunshine Act along with an update on the overall DC environment. Nuala O’Connor, president and CEO of the Center for Democracy and Technology started the group off with […]
Also posted in Advertising, Marketing, Patient Communication, Sales | Leave a comment

Japan’s Non-Hodgkin Lymphoma Market to Top $1 Billion by 2020

The Non-Hodgkin Lymphoma (NHL) treatment market in the Asia-Pacific (APAC) countries of India, Australia, China and Japan will expand from $1.1 billion in 2013 to $1.7 billion by 2020, with Japan remaining the largest contributor to growth, according to GBI Research. The company’s new report says that Japan had a 67.2% share of the APAC […]
Also posted in Global | Tagged , , , , , , | Leave a comment

What's the Future of European Health Policy?

What can be gleaned about the direction that health policy will take for the next five years under the new European Commission, scheduled to take office at the beginning of November? Peter O’ Donnell address this question in his new Applied Clinical Trials column here.
Also posted in Europe, Global, Guest Blog, Op-Ed, Regulatory | Tagged , , | Leave a comment

GSK Joins UK–South African Effort to Target Non-communicable Diseases

By Casey McDonald. GSK will weigh in on non-communicable diseases (NCDs) in Africa with a £1m contribution and a commitment of internal R&D expertise supporting researchers from South African institutions, the company announced this month.
Also posted in Emerging Markets, Global | Tagged , , , , | Leave a comment

Ebola Crisis Could Spur Broader R&D Efforts

Up until a few months ago, there was little industry interest or public support for developing vaccines and treatments to combat the Ebola virus. Now the rush is on to launch clinical trials of therapies with some potential effectiveness against the disease. The situation has also encouraged FDA and regulatory authorities to facilitate these efforts […]
Also posted in R&D, Regulatory | Tagged , , , | Leave a comment
  • Categories

  • Meta